Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04119050 · ClinicalTrials.gov registry record · Phase 2
Efficacy and Safety of M281 in Adults With Warm Autoimmune Hemolytic Anemia
A Phase 2 study of Warm Autoimmune Hemolytic Anemia, sponsored by Janssen Research & Development.
- Active
- Registry status
- Phase 2
- Development phase
- 118
- Enrollment target
- 20
- Study locations
NCT04119050 is a Phase 2 study of Warm Autoimmune Hemolytic Anemia that is active but no longer recruiting, run by Janssen Research & Development. The registered enrollment target is 118 participants. The trial reports 20 study locations across 10 states.
The verdict
NCT04119050, a Phase 2 study of Warm Autoimmune Hemolytic Anemia, is active but no longer recruiting, sponsored by Janssen Research & Development.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 2
- Development phase
- 118 participants
- Enrollment target
- 20
- Study locations
Study Summary
The main purpose of this study is to evaluate the efficacy and safety of M281 in participants with warm autoimmune hemolytic anemia (wAIHA).
Conditions Studied
Interventions
- DRUG Placebo
- DRUG M281
Study Locations (20)
Florida
- GNP Research - Cooper City
- University of Florida College of Medicine - Gainesville
- 21st Century Oncology - Jacksonville
- Lakes Research - Miami Lakes
- AdventHealth Cancer Institute - Orlando
- Children's Research Institute - St. Petersburg
California
- MemorialCare Medical Group - Fountain Valley
- University of Southern California - Los Angeles
- Compassionate Cancer Care - Riverside
- American Institute of Research - Whittier
New York
- Montefiore Medical Center - Lake Success
- Monter Cancer Center - Lake Success
- Hematology Oncology Associates of Rockland - Nyack
Colorado
- University of Colorado Anschutz Medical Campus - Aurora
Illinois
- Rush University Medical Center - Chicago
Kansas
- Alliance for Multispeciality Research - Merriam
Louisiana
- Tulane University School of Medicine - New Orleans
Michigan
- Henry Ford Medical Center - Detroit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 118 participants |
| Start Date | 2019-08-15 |
| Est. Completion | 2028-04-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04119050
The ClinicalTrials.gov registry entry for NCT04119050 describes a study currently listed as active not recruiting, categorized as Phase 2. The registered enrollment target is 118 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Janssen Research & Development, which has 593 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Warm Autoimmune Hemolytic Anemia appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT04119050 reports 20 study locations spanning 10 distinct geographic areas - top geographies include Florida, California, New York.
Frequently Asked Questions
What is clinical trial NCT04119050 about?
NCT04119050 is a clinical study titled "Efficacy and Safety of M281 in Adults With Warm Autoimmune Hemolytic Anemia". The main purpose of this study is to evaluate the efficacy and safety of M281 in participants with warm autoimmune hemolytic anemia (wAIHA).
What is the current status of trial NCT04119050?
This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 118 participants. The study started on 2019-08-15. Estimated completion is 2028-04-01.
What conditions does trial NCT04119050 study?
This clinical trial studies the following conditions: Warm Autoimmune Hemolytic Anemia.
What interventions are being tested in trial NCT04119050?
The interventions under investigation include: Placebo (DRUG), M281 (DRUG).
Who is sponsoring clinical trial NCT04119050?
This trial is sponsored by Janssen Research & Development, which has 593 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04119050 being conducted?
This trial has 20 study locations across California, Colorado, Florida, Illinois, Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Warm Autoimmune Hemolytic Anemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.